[{"NetIncomeLoss_1_Q1_USD":24936000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":89651000.0,"RestrictedCashCurrent_0_Q1_USD":5207000.0,"InventoryFinishedGoods_0_Q1_USD":35076000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":451000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":10172000.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q1_USD":10875000.0,"PaymentsForRestructuring_1_Q1_USD":247000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-46648000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":106450000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":4621000.0,"InventoryRawMaterialsAndSupplies_0_Q1_USD":5797000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":2876000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":-513000.0,"AssetsCurrent_0_Q1_USD":270721000.0,"LongTermDebtCurrent_0_Q1_USD":15000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":34686000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":1565000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":490000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":22222000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q1_USD":112000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":93283000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":20772668.0,"InventoryValuationReserves_0_Q1_USD":1065000.0,"DeferredTaxLiabilitiesInvestments_0_Q1_USD":48963000.0,"Assets_0_Q1_USD":643075000.0,"ShareBasedCompensation_1_Q1_USD":1944000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":18060000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":3750000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"DepreciationAndAmortization_1_Q1_USD":1925000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-408000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":13.03,"EarningsPerShareBasic_1_Q1_USD":-0.02,"MinorityInterest_0_Q1_USD":77892000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-221000.0,"AccruedBonusesCurrent_0_Q1_USD":9673000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":41797882.0,"OtherExpenses_1_Q1_USD":419000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":2457000.0,"AccountsReceivableNetCurrent_0_Q1_USD":89472000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-73000.0,"NumberOfReportableSegments_1_Q1_segment":2.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-14073000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_1_Q1_USD":5236000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.0271,"DepreciationDepletionAndAmortization_1_Q1_USD":7184000.0,"DebtInstrumentBasisSpreadOnVariableRate1_1_Q1_pure":0.0225,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-256000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.003,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":107526000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3051000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":23780000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_1_Q1_USD":36000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":124247000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":16402000.0,"Liabilities_0_Q1_USD":422793000.0,"OperatingLeaseLiability_0_Q1_USD":19362000.0,"LineOfCredit_0_Q1_USD":0.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":191000.0,"InventoryGross_0_Q1_USD":40873000.0,"DebtConversionConvertedInstrumentAmount1_1_Q1_USD":0.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":16000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":481000.0,"IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_1_Q1_USD":9157000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q1_pure":0.0289,"Goodwill_0_Q1_USD":53529000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":24455000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1983000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-1156000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18042000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":41797882.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":13057000.0,"LiabilitiesCurrent_0_Q1_USD":149027000.0,"AccountsPayableCurrent_0_Q1_USD":10283000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":129454000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":11987000.0,"LongTermDebtNoncurrent_0_Q1_USD":169731000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":18959000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":271042000.0,"GrossProfit_1_Q1_USD":59556000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.044,"ShortTermLeaseCost_1_Q1_USD":117000.0,"AdditionalPaidInCapital_0_Q1_USD":142923000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":220282000.0,"OperatingLeasePayments_1_Q1_USD":704000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":48963000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q1_USD":50000000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":157000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":29943000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-4000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8084000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.02,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-2612000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":42615000.0,"LeaseCost_1_Q1_USD":819000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":45791000.0,"DeferredFinanceCostsNet_0_Q1_USD":1029000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":81778000.0,"OperatingIncomeLoss_1_Q1_USD":21998000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":3811000.0,"InventoryNet_0_Q1_USD":39808000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":110410000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":13.03,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":83000.0,"OperatingLeaseCost_1_Q1_USD":702000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":643075000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":18550000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2960000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":947000.0,"StockholdersEquityChangeInReportingEntity_1_Q1_USD":-55929000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":25129000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":406000.0,"OtherLiabilitiesCurrent_0_Q1_USD":10161000.0,"StockholdersEquity_0_Q1_USD":142390000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1370000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":186250000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":3811000.0,"LongTermInvestments_0_Q1_USD":21158000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":136000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4621000.0,"TaxesPayableCurrent_0_Q1_USD":2657000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_Q1_USD":481000.0,"OtherNonrecurringExpense_1_Q1_USD":949000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1041000.0,"ProfitLoss_1_Q1_USD":24528000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q1_USD":3196000.0,"Ticker":"BVS","CIK":"1665988","name":"BIOVENTUS INC.","OfficialName":"Bioventus Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"774491745.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210513"}]